“…[8][9][10] Almost all anti-tumor drugs can damage normal cells while killing cancer cells, especially for added value, among which vigorous bone marrow hematopoietic cells are more seriously damaged. [11][12][13] To solve these drawbacks while exploring successful deliveries of anti-cancer drugs for drug deliveries as well as controlled drug release specifically for tumorous regions, various types of nanocarrier systems have been attracting wide attention over the last decade, which include organic materials, such as, liposomes, 14,15 micelles, 16,17 viruses, 18,19 and microcapsules, 20,21 as well as inorganic nanoparticles, such as, carbon nanotubes, 22 mesoporous silica nanospheres (MSNs) 23,24 and gold nanoparticles (Au NPs). 25,26 Recently, porous nanomaterials (microporous zeolites and mesoporous silica) in biomedical applications attract people's great attention.…”